Jia Yong, Quinn Christopher M, Bump Nancy J, Clark Kevin M, Clabbers Anca, Hardman Jennifer, Gagnon Andrew, Kamens Joanne, Tomlinson Medha J, Wishart Neil, Allen Hamish
Abbott Bioresearch Center, Department of Biochemistry, Worcester, MA 01605, USA.
Arch Biochem Biophys. 2005 Sep 1;441(1):64-74. doi: 10.1016/j.abb.2005.06.020.
Cancer osaka thyroid (COT), a human MAP 3 K, is essential for lipopolysaccharide activation of the Erk MAPK cascade in macrophages. COT 30--467 is insoluble, whereas low levels of COT 30--397 can be expressed, but this protein is unstable. However, both COT 30--467 and COT 30--397 are expressed in a soluble and stable form when produced in complex with the C-terminal half of p105. The k(cat) of COT 30--397 is reduced approximately 47--fold in the COT 30--467/p105 Delta N complex. COT prefers Mn(2+) to Mg(2+) as the ATP metal cofactor, exhibiting an unusually high ATP K(m) in the presence of Mg(2+). When using Mn(2+) as the cofactor, the ATP K(m) is reduced to a level typical of most kinases. In contrast, the binding affinity of COT for its other substrate MEK is cofactor independent. Our results using purified proteins indicate that p105 binding improves COT solubility and stability while down-regulating kinase activity, consistent with cellular data showing that p105 functions as an inhibitor of COT.
癌症大阪甲状腺蛋白(COT)是一种人类丝裂原活化蛋白激酶激酶激酶(MAP 3 K),对巨噬细胞中脂多糖激活细胞外信号调节激酶(Erk)丝裂原活化蛋白激酶(MAPK)级联反应至关重要。COT 30 - 467不溶,而低水平的COT 30 - 397可以表达,但这种蛋白质不稳定。然而,当与p105的C端半段形成复合物产生时,COT 30 - 467和COT 30 - 397均以可溶且稳定的形式表达。在COT 30 - 467/p105 ΔN复合物中,COT 30 - 397的催化常数(k(cat))降低了约47倍。COT更倾向于以锰离子(Mn(2+))而非镁离子(Mg(2+))作为ATP的金属辅因子,在镁离子存在的情况下表现出异常高的ATP米氏常数(K(m))。当使用锰离子作为辅因子时,ATP的K(m)降低到大多数激酶的典型水平。相比之下,COT对其另一种底物MEK的结合亲和力与辅因子无关。我们使用纯化蛋白的结果表明,p105结合提高了COT的溶解度和稳定性,同时下调了激酶活性,这与细胞数据显示p105作为COT的抑制剂的功能一致。